The neurodegenerative effects of selenium are inhibited by FOXO and PINK1/PTEN regulation of insulin/insulin-like growth factor signaling in Caenorhabditis elegans

Autor: Annette O. Estevez, Nathaniel J. Szewczyk, Miguel Estevez, Kathleen L. Morgan, David Gems
Jazyk: angličtina
Předmět:
PTEN
Time Factors
medicine.medical_treatment
Toxicology
Animals
Genetically Modified

Insulin-like growth factor
Insulin
Tensin
General Neuroscience
Neurodegeneration
food and beverages
Forkhead Transcription Factors
Neurodegenerative Diseases
3. Good health
Cell biology
medicine.anatomical_structure
Signal transduction
Signal Transduction
inorganic chemicals
Movement
Neuroscience(all)
Green Fluorescent Proteins
chemical and pharmacologic phenomena
Protein Serine-Threonine Kinases
Biology
Article
Selenium
Somatomedins
medicine
Animals
Insulin/insulin-like signaling
Caenorhabditis elegans
Caenorhabditis elegans Proteins
Transcription factor
Dose-Response Relationship
Drug

PINK1
fungi
Motor neuron
medicine.disease
Amyotrophic lateral sclerosis
Trace Elements
Disease Models
Animal

Gene Expression Regulation
Mutation
biology.protein
Neuroscience
Transcription Factors
Zdroj: Neurotoxicology
ISSN: 0161-813X
DOI: 10.1016/j.neuro.2013.12.012
Popis: Highlights • Insulin/insulin-like signaling reduction alters selenium-induced neurodegeneration. • Selenium induces nuclear translocation of DAF-16/FOXO3a. • DAF-16 overexpression decreases GABAergic and cholinergic motor neuron degeneration. • Loss of DAF-18/PTEN increases sensitivity to selenium-induced movement deficits. • Glutathione requires DAF-18/PINK-1 to improve selenium-induced movement deficits.
Exposures to high levels of environmental selenium have been associated with motor neuron disease in both animals and humans and high levels of selenite have been identified in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). We have shown previously that exposures to high levels of sodium selenite in the environment of Caenorhabditis elegans adult animals can induce neurodegeneration and cell loss resulting in motor deficits and death and that this is at least partially caused by a reduction in cholinergic signaling across the neuromuscular junction. Here we provide evidence that reduction in insulin/insulin-like (IIS) signaling alters response to high dose levels of environmental selenium which in turn can regulate the IIS pathway. Most specifically we show that nuclear localization and thus activation of the DAF-16/forkhead box transcription factor occurs in response to selenium exposure although this was not observed in motor neurons of the ventral cord. Yet, tissue specific expression and generalized overexpression of DAF-16 can partially rescue the neurodegenerative and behavioral deficits observed with high dose selenium exposures in not only the cholinergic, but also the GABAergic motor neurons. In addition, two modifiers of IIS signaling, PTEN (phosphatase and tensin homolog, deleted on chromosome 10) and PINK1 (PTEN-induced putative kinase 1) are required for the cellular antioxidant reduced glutathione to mitigate the selenium-induced movement deficits. Studies have suggested that environmental exposures can lead to ALS or other neurological diseases and this model of selenium-induced neurodegeneration developed in a genetically tractable organism provides a tool for examining the combined roles of genetics and environment in the neuro-pathologic disease process.
Databáze: OpenAIRE